Protective Effects of Oral L-Arginine CI-AKI

NCT02455960 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Contrast Induced AKI

Interventions

DIETARY_SUPPLEMENT: L-arginine
DIETARY_SUPPLEMENT: Placebo

Sponsor

Phramongkutklao College of Medicine and Hospital